News

28 October 2025

Phage-antibiotics synergy and nanotechnology interventions in the management of drug resistance among bacterial pathogens: A scoping review

24 October 2025

Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy

24 October 2025

Phenotypic and genotypic characterization of probiotic strains in the context of antimicrobial resistance

24 October 2025

Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus

16 October 2025

Localized and controlled antibiotic therapy via microneedles: A biomedical approach to antimicrobial resistance

10 October 2025

The Emerging Resistance Index: tracking early resistance to new antibiotics

8 October 2025

Winners Announced for the 2025 Vivli AMR Surveillance Data Challenge, funded by Johnson & Johnson, Paratek, Pfizer, and NIH

6 October 2025

Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic

6 October 2025

AMR Drugs and Diagnostics Must Evolve in Tandem

6 October 2025

Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025

3 October 2025

Innovative Approaches to Combat Antimicrobial Resistance: A Review of Emerging Therapies and Technologies

30 September 2025

New European Partnership on One Health AMR: €253 million for research and innovation against antimicrobial resistance

29 September 2025

A comprehensive review of advanced strategies to combat antimicrobial resistance

29 September 2025

Antimicrobial resistance detection: Rapid transition to point-of-care platforms

22 September 2025

Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives

22 September 2025

Revitalizing the antibiotic pipeline by implementing new R&D pull incentives

18 September 2025

Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery

12 September 2025

Automated phage therapy in smart hospitals: a hypothesis for an AI, metagenomics, and IoT pipeline to treat resistant infections

10 September 2025

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27

2 September 2025

Mitigating antimicrobial resistance by innovative solutions in AI (MARISA): a modified James Lind Alliance analysis

27 August 2025

Towards an Interpretable Machine Learning Model for Predicting Antimicrobial Resistance

25 August 2025

Gamified interventions to educate healthcare professionals on the rational use of antimicrobials

22 August 2025

Prediction of antibiotic resistance from antibiotic susceptibility testing results from surveillance data using machine learning

18 August 2025

FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistance

27 July 2025

Antibiotic Resistance Microbiology Dataset (ARMD): A Resource for Antimicrobial Resistance from EHRs

27 July 2025

Barriers and facilitators to digital technology application for antimicrobial resistance surveillance: A co-produced qualitative synthesis

26 June 2025

Harnessing artificial intelligence for predictive modeling in combating antimicrobial resistance: a call for integration and innovation

26 June 2025

Requirements and Considerations for Effective Implementation of Integrated One Health Antimicrobial Resistance Research

23 June 2025

European Partnership on One Health Antimicrobial Resistance

21 June 2025

Optimized strategies for designing antimicrobial peptides targeting multidrug-resistant Gram-negative bacteria

18 June 2025

Advancing AMR Surveillance: Confluence of One Health and Big Data Integration

18 June 2025

Understanding antimicrobial resistance (AMR) mechanisms and advancements in AMR diagnostics

16 June 2025

Leveraging artificial intelligence to combat antimicrobial resistance in geriatric care

13 June 2025

Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security

13 June 2025

Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria

30 May 2025

Rapid antimicrobial susceptibility tests performed by self-diluting microfluidic chips for drug resistance studies and point-of-care diagnostics

22 May 2025

AI system developed to identify alternative antibiotics for drug-resistant infections

13 May 2025

AmrProfiler: a comprehensive tool for identifying antimicrobial resistance genes and mutations across species

9 May 2025

Efforts to develop therapeutic agents for bacterial infections to fight against AMR

5 May 2025

An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens

2 May 2025

Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis

30 April 2025

Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis

26 April 2025

Antibiotic conjugates: Using molecular Trojan Horses to overcome drug resistance

25 April 2025

The Global Challenge of Antimicrobial Resistance: Patent filing analysis a decade on

23 April 2025

Nanobiosensors for Antimicrobial Resistance Surveillance: Possibilities and Challenges

18 April 2025

Barriers to the widespread adoption of diagnostic artificial intelligence for preventing antimicrobial resistance

16 April 2025

Digital vision for antimicrobial stewardship in England

13 April 2025

Upcycling of Expanded Polystyrene Waste into Multifunctional Antibacterial Platforms for Microbial Control

7 April 2025

Antifungal agents in clinical and preclinical development: overview and analysis

7 April 2025

GP or ChatGPT? Ability of large language models (LLMs) to support general practitioners when prescribing antibiotics